Optical coherence tomography angiography changes in patients with hemoglobinopathy

Abstract

Aim: The aim of this study is to evaluate retinal vascular changes in patients with sickle cell disease (SCD) and beta-thalassemia with optical coherence tomography angiography (OCT-A). Methods: For this purpose, 98 patients with SCD, 75 patients with beta-thalassemia, and 100 healthy controls in Mersin University Hospital between January 1, 2020, and November 1, 2021, were included in this study. OCT-A imaging was performed with ZEISS AngioPlex OCT angiography (Carl Zeiss Meditec, Dublin, CA, USA). Results: All OCT-A parameters (FAZ area, perimeter, circularity, vessel, and perfusion density) were found to be statistically significantly different in both patients with thalassemia and patients with sickle cell disease when compared to the controls. Conclusions: In conclusion, retinopathy related to both hemoglobinopathy subgroups can be diagnosed and followed up with OCT-A. It was also found that OCT-A parameters are affected before the development of clinically detectable retinopathy.